Loading, Please Wait...
BRENTWOOD, Tenn., March 06, 2019 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of Innovative Medical Advancements and Care, specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces the establishment of a dedicated corporate accounts division: IMAC Regeneration Centers Corporate Partnerships. This division will focus on partnerships with self-funded employers seeking to provide employees with non-surgical solutions to spine, knee, hip, shoulder and other musculoskeletal conditions at a significant cost savings compared to surgery.
Laura Fristoe, who joined IMAC in 2016 as Director of Business Development, has been named Vice President, Corporate Partnerships and will lead this initiative. She will report to Jeffrey Ervin, CEO of IMAC.
Ms. Fristoe has 20 years of experience in the healthcare industry including Bayer Pharmaceuticals, Johnson & Johnson, Genesis Therapeutic Systems and American Red Cross. Throughout her career, Ms. Fristoe’s primary focus has been on leadership, business development, product launches and sales strategy where she has received multiple awards for outstanding achievement. In 2018, Ms. Fristoe was promoted to Director of Investor Relations and Communications with a primary role in IMAC’s initial public offering.
Commenting on her appointment, Ms. Fristoe said, “As a leading provider of non-surgical regenerative-rehabilitative solutions for chronic musculoskeletal conditions, IMAC Regeneration Centers offers the self-insured employer a tremendous savings in treating their most costly claims. Providing the highest quality care along with the best patient outcomes, while saving the employer between 50% and 75% without surgery or opioids, is how IMAC is impacting the trajectory of healthcare. I am excited to expand IMAC's national footprint through corporate partnerships and increase awareness of the significant advantages of our regenerative-rehabilitative solutions."
“Laura has proven herself to be a dynamic leader at IMAC, and her professional experience is ideality suited to lead our new corporate accounts division,” said Mr. Ervin. “Building upon our initial public offering last month, IMAC is broadening its sights and capabilities in the healthcare industry. Our focus on offering full service, non-surgical innovations for orthopedic conditions has led us to recast what our name stands for – Innovative Medical Advancements and Care – and to embark on broadening our patient base and service offerings. By promoting our full range of healthcare services, including regenerative medicine, we believe we are in an excellent position to bring a new level of value-added partnerships not only to self-funded employers, but third-party payors, insurance brokers and coalitions,” Mr. Ervin concluded.
About IMAC Holdings, Inc.
IMAC Holdings was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life science advancements with traditional medical care for movement restricting diseases and conditions. It owns or manages outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes, opening two Ozzie Smith IMAC Regeneration Centers, two David Price IMAC Regeneration Centers, and a Tony Delk IMAC Regeneration Center. IMAC’s outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries without surgery or opioids.
Safe Harbor Statement
This press release contains forward-looking statements. These forward-looking statements, and terms such as “anticipate,” “expect,” “believe,” “may,” “will,” “should” or other comparable terms, are based largely on IMAC's expectations and are subject to a number of risks and uncertainties, certain of which are beyond IMAC's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the skills and experience necessary to meet customers’ requirements, and its ability to protect its intellectual property. IMAC encourages you to review other factors that may affect its future results in its registration statement and in its other filings with the Securities and Exchange Commission. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will in fact occur.
More information about IMAC Holdings, Inc. is available at www.imacregeneration.com
IMAC Press Contact:
LHA Investor Relations
Kim Sutton Golodetz
# # #